Investigation of a synthetic peptide as immunogen for a variant epidermal growth factor receptor associated with gliomas
- 31 July 1993
- journal article
- Published by Elsevier BV in Journal of Neuroimmunology
- Vol. 46 (1-2), 165-173
- https://doi.org/10.1016/0165-5728(93)90246-u
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth.The Journal of Immunology, 1992
- High-Titer HIV-1 Neutralizing Antibody Response of Rhesus Macaques to gp160 andenvPeptidesAIDS Research and Human Retroviruses, 1992
- Adjuvanticity of Stearyl Tyrosine on the Antibody Response to Peptide 503-535 from HIV gp160Viral Immunology, 1992
- Deletion-mutant epidermal growth factor receptor in human gliomas: Effect of type II mutation on receptor functionBiochemical and Biophysical Research Communications, 1991
- Production and characterisation of monoclonal antibodies to parathyroid hormone (1–34)Journal of Immunological Methods, 1991
- Generation of anti-peptide and anti-protein sera effect of peptide presentation on immunogenicityJournal of Immunological Methods, 1991
- A Deletion Mutation within the Ligand Binding Domain Is Responsible for Activation of Epidermal Growth Factor Receptor Gene in Human Brain TumorsJapanese Journal of Cancer Research, 1990
- The influence of different adjuvants on the immune response to a synthetic peptide comprising amino acid residues 9–21 of herpes simplex virus type 1 glycoprotein DJournal of Immunological Methods, 1989
- Production and characterization of monoclonal antibodies to the c-erbB-2 proto-oncogene protein using a synthetic peptide immunogenBiochemical Society Transactions, 1988
- Preparation of peptide-protein immunogens using N-succinimidyl bromoacetate as a heterobifunctional crosslinking reagentAnalytical Biochemistry, 1986